Enviar búsqueda
Cargar
Ngs part ii 2013
•
1 recomendación
•
1,011 vistas
Elsa von Licy
Seguir
Denunciar
Compartir
Denunciar
Compartir
1 de 58
Descargar ahora
Descargar para leer sin conexión
Recomendados
DNA sequencing is the process of determining the precise order of nucleotides within a DNA molecule. Discuss the application of next generation sequencing in cancer treatment.
GTC group 8 - Next Generation Sequencing
GTC group 8 - Next Generation Sequencing
Yanqi Chan
Next generation sequencing
overview on Next generation sequencing in breast csncer
overview on Next generation sequencing in breast csncer
Seham Al-Shehri
1. Be familiar with next generation molecular diagnostic techniques that can provide guidance in clinical decision making 2. Identify the utility of these diagnostic approaches with some examples 3. Be aware of the challenges that exist in implementing these tools as part of the routine clinical decision making process, especially in resource limited settings
Clinical molecular diagnostics for drug guidance
Clinical molecular diagnostics for drug guidance
Nikesh Shah
VALIDATION OF NGS SEQUENCING BY SANGER SEQUENCING
VALIDATION OF NGS SEQUENCING BY SANGER SEQUENCING
NARRANAGAPAVANKUMAR
Talk on High-Throughput Sequencing: Overview and Selected Applications for Masters students. Nov 9th 2011
High-Throughput Sequencing
High-Throughput Sequencing
Mark Pallen
Meningioma’s display a broad spectrum of clinical, histological and cytogenetic features even within the same WHO grade often posing a challenge for classification and prognostic stratification. In this webinar, we will describe our experience of using targeted amplicon sequencing to develop rapid clinical sequencing system to identify and confirm the meningioma genotype in just two weeks. In addition the details of the three meningioma categories and the genes involved will be discussed.
Developing a Rapid Clinical Sequencing System to Classify Meningioma: Meet th...
Developing a Rapid Clinical Sequencing System to Classify Meningioma: Meet th...
QIAGEN
Impact of Plant Genome sequencing in Crop improvement
Plant genome sequencing and crop improvement
Plant genome sequencing and crop improvement
Ragavendran Abbai
Aug2013 Heidi Rehm integrating large scale sequencing into clinical practice
Aug2013 Heidi Rehm integrating large scale sequencing into clinical practice
GenomeInABottle
Recomendados
DNA sequencing is the process of determining the precise order of nucleotides within a DNA molecule. Discuss the application of next generation sequencing in cancer treatment.
GTC group 8 - Next Generation Sequencing
GTC group 8 - Next Generation Sequencing
Yanqi Chan
Next generation sequencing
overview on Next generation sequencing in breast csncer
overview on Next generation sequencing in breast csncer
Seham Al-Shehri
1. Be familiar with next generation molecular diagnostic techniques that can provide guidance in clinical decision making 2. Identify the utility of these diagnostic approaches with some examples 3. Be aware of the challenges that exist in implementing these tools as part of the routine clinical decision making process, especially in resource limited settings
Clinical molecular diagnostics for drug guidance
Clinical molecular diagnostics for drug guidance
Nikesh Shah
VALIDATION OF NGS SEQUENCING BY SANGER SEQUENCING
VALIDATION OF NGS SEQUENCING BY SANGER SEQUENCING
NARRANAGAPAVANKUMAR
Talk on High-Throughput Sequencing: Overview and Selected Applications for Masters students. Nov 9th 2011
High-Throughput Sequencing
High-Throughput Sequencing
Mark Pallen
Meningioma’s display a broad spectrum of clinical, histological and cytogenetic features even within the same WHO grade often posing a challenge for classification and prognostic stratification. In this webinar, we will describe our experience of using targeted amplicon sequencing to develop rapid clinical sequencing system to identify and confirm the meningioma genotype in just two weeks. In addition the details of the three meningioma categories and the genes involved will be discussed.
Developing a Rapid Clinical Sequencing System to Classify Meningioma: Meet th...
Developing a Rapid Clinical Sequencing System to Classify Meningioma: Meet th...
QIAGEN
Impact of Plant Genome sequencing in Crop improvement
Plant genome sequencing and crop improvement
Plant genome sequencing and crop improvement
Ragavendran Abbai
Aug2013 Heidi Rehm integrating large scale sequencing into clinical practice
Aug2013 Heidi Rehm integrating large scale sequencing into clinical practice
GenomeInABottle
Tutorial for the analysis of DNA-seq data. Application in Hereditary cancer.
Bioinformatics tools for NGS data analysis
Bioinformatics tools for NGS data analysis
Despoina Kalfakakou
This presentation covers the basics on what Next Generational Sequencing is and some terminology needed in order to understand the process.
Basic Steps of the NGS Method
Basic Steps of the NGS Method
USD Bioinformatics
Next generation sequencing in pharmacogenomics
Next generation sequencing in pharmacogenomics
Dr. Gerry Higgins
APPLICATION OF NEXT GENERATION SEQUENCING (NGS) IN CANCER TREATMENT
APPLICATION OF NEXT GENERATION SEQUENCING (NGS) IN CANCER TREATMENT
APPLICATION OF NEXT GENERATION SEQUENCING (NGS) IN CANCER TREATMENT
Dinie Fariz
DNA mutations have been implicated in several diseases, particularly cancer. NGS presents an ideal technology to efficiently profile the multitude of mutations in a high throughput manner. In 2001 the first draft of human genome was published. Since then many major milestones have been reached. Do you know when PIK3CA was identified in colon cancer? When was Olaparib for ovarian cancer treatment? This infographic traces the major clinical research milestones starting from the first draft of the human genome.
Next-Generation Sequencing Clinical Research Milestones Infographic
Next-Generation Sequencing Clinical Research Milestones Infographic
QIAGEN
Advanced prostate cancer is highly heterogeneous but this inter-patient heterogeneity has until recently not been understood. We have through an international research effort dissected the molecular landscape of advanced castration resistant prostate, elucidating key molecular targets in this group of diseases. We have also shown that PARP inhibitors have antitumor activity against a significant proportion of these cancers, mainly in men whose cancers harbor DNA repair defects.
Translational Genomics and Prostate Cancer: Meet the NGS Experts Series Part 2
Translational Genomics and Prostate Cancer: Meet the NGS Experts Series Part 2
QIAGEN
The so-called “next-generation” sequencing (NGS) technologies allows us, in a short time and in parallel, to sequence massive amounts of DNA, overcoming the limitations of the original Sanger sequencing methods used to sequence the first human genome. NGS technologies have had an enormous impact on biomedical research within a short time frame. This talk will give an overview of these applications with specific examples from Mendelian genomics and cancer research. #h2ony
Next Generation Sequencing and its Applications in Medical Research - Frances...
Next Generation Sequencing and its Applications in Medical Research - Frances...
Sri Ambati
In recent years, advances in next-generation sequencing (NGS) technologies have enabled faster and cheaper methods for uncovering the genetic basis of disease. For cancer, NGS based screening for known tumour subtypes can inform diagnosis and allow the clinician to tailor a specific therapy based on testing outcome. Here we present the validation of one such NGS based kit approved for CE-IVD* use to screen for specific chromosomal translocations in non-small cell lung cancer (NSCLC) samples by targeting specific breakpoints in known fusion transcripts. The kit tested (Oncomine™ Solid Tumour Fusion Transcript Kit) included a single primer poolcontaining amplicon designs to simultaneously screen for over 75 specific rearrangements involving the receptor tyrosine kinase (RTK) genes ALK, RET and ROS1 as well as NTRK1. The panel was compatible with formalin-fixed paraffin-embedded (FFPE) lung tumour samples and achieved high sensitivity down to 10 ng of RNA input. In addition, amplicon assays designed at the 5’ and 3’ ends the RTK genes provide non-specific evidence that a translocation exists in a sample by comparing expression imbalance between the two ends. Validation testing was carried out at three external clinical laboratories (CLIA, CAP, INAB). In addition to positive and negative control samples, each site contributed FFPE lung tumour samples for which ALK fusion status was known prior to NGS library preparation carried out using the Ion AmpliSeq workflow. For site-specific samples (n=144, 16 samples per sequencing run), high concordance, sensitivity and specificity were measured at 97.2%, 90.5% and 98.4%, respectively.
Clinical Validation of an NGS-based (CE-IVD) Kit for Targeted Detection of Ge...
Clinical Validation of an NGS-based (CE-IVD) Kit for Targeted Detection of Ge...
Thermo Fisher Scientific
This year's 3rd Annual TCGC: The Clinical Genome Conference, held June 10-12, 2014 in San Francisco, is a three-day event that weaves together the science of sequencing and the business of implementing genomics in the clinic. It uniquely illustrates the mutual influence of those areas and the need to therefore consider the needs, challenges and opportunities of both - from next-generation sequencing and variant interpretation to insurance reimbursement and electronic health records - throughout the entire research process.Learn more at http://www.clinicalgenomeconference.com
The Clinical Genome Conference 2014
The Clinical Genome Conference 2014
Nicole Proulx
genetics in neurology
Ngs presentation
Ngs presentation
Chakradhar Reddy
Clinical Applications of Next Generation Sequencing
Clinical Applications of Next Generation Sequencing
Clinical Applications of Next Generation Sequencing
Bell Symposium & MSP Seminar
Summary trends of NGS in PGS
Next generation sequencing in preimplantation genetic screening (NGS in PGS)
Next generation sequencing in preimplantation genetic screening (NGS in PGS)
Mahidol University, Thailand
Evolution of DNA Sequencing by Jonathan Eisen (for UC Davis Workshop in Applied Phylogenetics at Bodega Bay Marine Lab)
Evolution of DNA Sequencing by Jonathan Eisen
Evolution of DNA Sequencing by Jonathan Eisen
Jonathan Eisen
140127 abrf interlaboratory study proposal
140127 abrf interlaboratory study proposal
GenomeInABottle
Sophie F. summer Poster Final
Sophie F. summer Poster Final
Sophie Friedheim
Pancreatic cancer is a uniquely lethal malignancy characterized by frequent mutations in KRAS, CDKN2A, SMAD4, TP53 and many others. We have shown that KRAS mutation can be detected in cell-free, circulating tumor DNA (ctDNA) isolated from the plasma in a subset of patients and is associated with poor prognosis. The ability to simultaneously detect multiple pancreatic cancer-specific mutations in ctDNA would open a new avenue for detection of clinically-relevant mutations. In this study, we performed ultra-deep sequencing of ctDNA from advanced pancreatic cancer patients prior to treatment with Gemcitabine and Erlotinib following target enrichment. Somatic, non-synonymous variants were identified in 29 different genes at allele frequencies typically less than 0.5%. Updated results of ultra-deep NGS analysis will be presented.
Utilization of NGS to Identify Clinically-Relevant Mutations in cfDNA: Meet t...
Utilization of NGS to Identify Clinically-Relevant Mutations in cfDNA: Meet t...
QIAGEN
Introduction to next generation sequencing (NGS); NGS data; data management of NGS data; third generation sequencing; NGS pipelines; NGS experimental design
Data Management for Quantitative Biology - Data sources (Next generation tech...
Data Management for Quantitative Biology - Data sources (Next generation tech...
QBiC_Tue
Use of Next Generation Sequencing for Whole Genome Analysis of Pathogens - Dr. Douglas Marthaler, Veterinary Diagnostic Laboratory, College of Veterinary Medicine, University of Minnesota, from the 2016 Allen D. Leman Swine Conference, September 17-20, 2016, St. Paul, Minnesota, USA. More presentations at http://www.swinecast.com/2016-leman-swine-conference-material
Dr. Douglas Marthaler - Use of Next Generation Sequencing for Whole Genome An...
Dr. Douglas Marthaler - Use of Next Generation Sequencing for Whole Genome An...
John Blue
Next Generation Sequencing for Cancer Genomics 101
20170209 ngs for_cancer_genomics_101
20170209 ngs for_cancer_genomics_101
Ino de Bruijn
GTC SCT60103 Group 5 Assignment
Next Generation Sequencing
Next Generation Sequencing
JoshuaLee309
kinetic simulation/modeling; Assay development; Enzymology; Instrumental analysis; protein engineering; Bioinformatics/pathway analysis
Kai Li's skills
Kai Li's skills
Kai Li
ok
C1 clef pour_la_neuro
C1 clef pour_la_neuro
Elsa von Licy
Más contenido relacionado
La actualidad más candente
Tutorial for the analysis of DNA-seq data. Application in Hereditary cancer.
Bioinformatics tools for NGS data analysis
Bioinformatics tools for NGS data analysis
Despoina Kalfakakou
This presentation covers the basics on what Next Generational Sequencing is and some terminology needed in order to understand the process.
Basic Steps of the NGS Method
Basic Steps of the NGS Method
USD Bioinformatics
Next generation sequencing in pharmacogenomics
Next generation sequencing in pharmacogenomics
Dr. Gerry Higgins
APPLICATION OF NEXT GENERATION SEQUENCING (NGS) IN CANCER TREATMENT
APPLICATION OF NEXT GENERATION SEQUENCING (NGS) IN CANCER TREATMENT
APPLICATION OF NEXT GENERATION SEQUENCING (NGS) IN CANCER TREATMENT
Dinie Fariz
DNA mutations have been implicated in several diseases, particularly cancer. NGS presents an ideal technology to efficiently profile the multitude of mutations in a high throughput manner. In 2001 the first draft of human genome was published. Since then many major milestones have been reached. Do you know when PIK3CA was identified in colon cancer? When was Olaparib for ovarian cancer treatment? This infographic traces the major clinical research milestones starting from the first draft of the human genome.
Next-Generation Sequencing Clinical Research Milestones Infographic
Next-Generation Sequencing Clinical Research Milestones Infographic
QIAGEN
Advanced prostate cancer is highly heterogeneous but this inter-patient heterogeneity has until recently not been understood. We have through an international research effort dissected the molecular landscape of advanced castration resistant prostate, elucidating key molecular targets in this group of diseases. We have also shown that PARP inhibitors have antitumor activity against a significant proportion of these cancers, mainly in men whose cancers harbor DNA repair defects.
Translational Genomics and Prostate Cancer: Meet the NGS Experts Series Part 2
Translational Genomics and Prostate Cancer: Meet the NGS Experts Series Part 2
QIAGEN
The so-called “next-generation” sequencing (NGS) technologies allows us, in a short time and in parallel, to sequence massive amounts of DNA, overcoming the limitations of the original Sanger sequencing methods used to sequence the first human genome. NGS technologies have had an enormous impact on biomedical research within a short time frame. This talk will give an overview of these applications with specific examples from Mendelian genomics and cancer research. #h2ony
Next Generation Sequencing and its Applications in Medical Research - Frances...
Next Generation Sequencing and its Applications in Medical Research - Frances...
Sri Ambati
In recent years, advances in next-generation sequencing (NGS) technologies have enabled faster and cheaper methods for uncovering the genetic basis of disease. For cancer, NGS based screening for known tumour subtypes can inform diagnosis and allow the clinician to tailor a specific therapy based on testing outcome. Here we present the validation of one such NGS based kit approved for CE-IVD* use to screen for specific chromosomal translocations in non-small cell lung cancer (NSCLC) samples by targeting specific breakpoints in known fusion transcripts. The kit tested (Oncomine™ Solid Tumour Fusion Transcript Kit) included a single primer poolcontaining amplicon designs to simultaneously screen for over 75 specific rearrangements involving the receptor tyrosine kinase (RTK) genes ALK, RET and ROS1 as well as NTRK1. The panel was compatible with formalin-fixed paraffin-embedded (FFPE) lung tumour samples and achieved high sensitivity down to 10 ng of RNA input. In addition, amplicon assays designed at the 5’ and 3’ ends the RTK genes provide non-specific evidence that a translocation exists in a sample by comparing expression imbalance between the two ends. Validation testing was carried out at three external clinical laboratories (CLIA, CAP, INAB). In addition to positive and negative control samples, each site contributed FFPE lung tumour samples for which ALK fusion status was known prior to NGS library preparation carried out using the Ion AmpliSeq workflow. For site-specific samples (n=144, 16 samples per sequencing run), high concordance, sensitivity and specificity were measured at 97.2%, 90.5% and 98.4%, respectively.
Clinical Validation of an NGS-based (CE-IVD) Kit for Targeted Detection of Ge...
Clinical Validation of an NGS-based (CE-IVD) Kit for Targeted Detection of Ge...
Thermo Fisher Scientific
This year's 3rd Annual TCGC: The Clinical Genome Conference, held June 10-12, 2014 in San Francisco, is a three-day event that weaves together the science of sequencing and the business of implementing genomics in the clinic. It uniquely illustrates the mutual influence of those areas and the need to therefore consider the needs, challenges and opportunities of both - from next-generation sequencing and variant interpretation to insurance reimbursement and electronic health records - throughout the entire research process.Learn more at http://www.clinicalgenomeconference.com
The Clinical Genome Conference 2014
The Clinical Genome Conference 2014
Nicole Proulx
genetics in neurology
Ngs presentation
Ngs presentation
Chakradhar Reddy
Clinical Applications of Next Generation Sequencing
Clinical Applications of Next Generation Sequencing
Clinical Applications of Next Generation Sequencing
Bell Symposium & MSP Seminar
Summary trends of NGS in PGS
Next generation sequencing in preimplantation genetic screening (NGS in PGS)
Next generation sequencing in preimplantation genetic screening (NGS in PGS)
Mahidol University, Thailand
Evolution of DNA Sequencing by Jonathan Eisen (for UC Davis Workshop in Applied Phylogenetics at Bodega Bay Marine Lab)
Evolution of DNA Sequencing by Jonathan Eisen
Evolution of DNA Sequencing by Jonathan Eisen
Jonathan Eisen
140127 abrf interlaboratory study proposal
140127 abrf interlaboratory study proposal
GenomeInABottle
Sophie F. summer Poster Final
Sophie F. summer Poster Final
Sophie Friedheim
Pancreatic cancer is a uniquely lethal malignancy characterized by frequent mutations in KRAS, CDKN2A, SMAD4, TP53 and many others. We have shown that KRAS mutation can be detected in cell-free, circulating tumor DNA (ctDNA) isolated from the plasma in a subset of patients and is associated with poor prognosis. The ability to simultaneously detect multiple pancreatic cancer-specific mutations in ctDNA would open a new avenue for detection of clinically-relevant mutations. In this study, we performed ultra-deep sequencing of ctDNA from advanced pancreatic cancer patients prior to treatment with Gemcitabine and Erlotinib following target enrichment. Somatic, non-synonymous variants were identified in 29 different genes at allele frequencies typically less than 0.5%. Updated results of ultra-deep NGS analysis will be presented.
Utilization of NGS to Identify Clinically-Relevant Mutations in cfDNA: Meet t...
Utilization of NGS to Identify Clinically-Relevant Mutations in cfDNA: Meet t...
QIAGEN
Introduction to next generation sequencing (NGS); NGS data; data management of NGS data; third generation sequencing; NGS pipelines; NGS experimental design
Data Management for Quantitative Biology - Data sources (Next generation tech...
Data Management for Quantitative Biology - Data sources (Next generation tech...
QBiC_Tue
Use of Next Generation Sequencing for Whole Genome Analysis of Pathogens - Dr. Douglas Marthaler, Veterinary Diagnostic Laboratory, College of Veterinary Medicine, University of Minnesota, from the 2016 Allen D. Leman Swine Conference, September 17-20, 2016, St. Paul, Minnesota, USA. More presentations at http://www.swinecast.com/2016-leman-swine-conference-material
Dr. Douglas Marthaler - Use of Next Generation Sequencing for Whole Genome An...
Dr. Douglas Marthaler - Use of Next Generation Sequencing for Whole Genome An...
John Blue
Next Generation Sequencing for Cancer Genomics 101
20170209 ngs for_cancer_genomics_101
20170209 ngs for_cancer_genomics_101
Ino de Bruijn
GTC SCT60103 Group 5 Assignment
Next Generation Sequencing
Next Generation Sequencing
JoshuaLee309
La actualidad más candente
(20)
Bioinformatics tools for NGS data analysis
Bioinformatics tools for NGS data analysis
Basic Steps of the NGS Method
Basic Steps of the NGS Method
Next generation sequencing in pharmacogenomics
Next generation sequencing in pharmacogenomics
APPLICATION OF NEXT GENERATION SEQUENCING (NGS) IN CANCER TREATMENT
APPLICATION OF NEXT GENERATION SEQUENCING (NGS) IN CANCER TREATMENT
Next-Generation Sequencing Clinical Research Milestones Infographic
Next-Generation Sequencing Clinical Research Milestones Infographic
Translational Genomics and Prostate Cancer: Meet the NGS Experts Series Part 2
Translational Genomics and Prostate Cancer: Meet the NGS Experts Series Part 2
Next Generation Sequencing and its Applications in Medical Research - Frances...
Next Generation Sequencing and its Applications in Medical Research - Frances...
Clinical Validation of an NGS-based (CE-IVD) Kit for Targeted Detection of Ge...
Clinical Validation of an NGS-based (CE-IVD) Kit for Targeted Detection of Ge...
The Clinical Genome Conference 2014
The Clinical Genome Conference 2014
Ngs presentation
Ngs presentation
Clinical Applications of Next Generation Sequencing
Clinical Applications of Next Generation Sequencing
Next generation sequencing in preimplantation genetic screening (NGS in PGS)
Next generation sequencing in preimplantation genetic screening (NGS in PGS)
Evolution of DNA Sequencing by Jonathan Eisen
Evolution of DNA Sequencing by Jonathan Eisen
140127 abrf interlaboratory study proposal
140127 abrf interlaboratory study proposal
Sophie F. summer Poster Final
Sophie F. summer Poster Final
Utilization of NGS to Identify Clinically-Relevant Mutations in cfDNA: Meet t...
Utilization of NGS to Identify Clinically-Relevant Mutations in cfDNA: Meet t...
Data Management for Quantitative Biology - Data sources (Next generation tech...
Data Management for Quantitative Biology - Data sources (Next generation tech...
Dr. Douglas Marthaler - Use of Next Generation Sequencing for Whole Genome An...
Dr. Douglas Marthaler - Use of Next Generation Sequencing for Whole Genome An...
20170209 ngs for_cancer_genomics_101
20170209 ngs for_cancer_genomics_101
Next Generation Sequencing
Next Generation Sequencing
Destacado
kinetic simulation/modeling; Assay development; Enzymology; Instrumental analysis; protein engineering; Bioinformatics/pathway analysis
Kai Li's skills
Kai Li's skills
Kai Li
ok
C1 clef pour_la_neuro
C1 clef pour_la_neuro
Elsa von Licy
ok
Rainville pierre
Rainville pierre
Elsa von Licy
ok
L agressivite en psychanalyse (21 pages 184 ko)
L agressivite en psychanalyse (21 pages 184 ko)
Elsa von Licy
ok
Neuropsychophysiologie
Neuropsychophysiologie
Elsa von Licy
Stratégie Décisions Incertitude
Strategie Decisions Incertitude Actes conference fnege xerfi
Strategie Decisions Incertitude Actes conference fnege xerfi
Elsa von Licy
Chicago practices talk v2
Styles of Scientific Reasoning, Scientific Practices and Argument in Science ...
Styles of Scientific Reasoning, Scientific Practices and Argument in Science ...
Elsa von Licy
Destacado
(7)
Kai Li's skills
Kai Li's skills
C1 clef pour_la_neuro
C1 clef pour_la_neuro
Rainville pierre
Rainville pierre
L agressivite en psychanalyse (21 pages 184 ko)
L agressivite en psychanalyse (21 pages 184 ko)
Neuropsychophysiologie
Neuropsychophysiologie
Strategie Decisions Incertitude Actes conference fnege xerfi
Strategie Decisions Incertitude Actes conference fnege xerfi
Styles of Scientific Reasoning, Scientific Practices and Argument in Science ...
Styles of Scientific Reasoning, Scientific Practices and Argument in Science ...
Similar a Ngs part ii 2013
Liquid biopsies enable us to monitor the evolution of genetic aberrations in primary tumors as they shed the tumor cells into the circulation. The limitation is the ability to detect these low frequency genetic aberrations in a consistent manner to understand short- and long-term implications and how this information will be used in the clinic. This slidedeck will cover the challenges and solutions associated with multiple steps as one starts with liquid biopsy and move towards finding a new biomarker.
Step by Step, from Liquid Biopsy to a Genomic Biomarker: Liquid Biopsy Series...
Step by Step, from Liquid Biopsy to a Genomic Biomarker: Liquid Biopsy Series...
QIAGEN
Ngs webinar 2013
Ngs webinar 2013
Elsa von Licy
Oncogenomics 2013
Oncogenomics 2013
Elsa von Licy
2013 02-14 - ngs webinar - sellappan
2013 02-14 - ngs webinar - sellappan
Elsa von Licy
SANGER SEQUENCING - 1st generation sequencing Sanger Sequencing Workflow: PCR amplification (target enrichment) PCR purification (primer, dNTPs) Sequencing reaction (bi-directional) Sequencing purification (primer, dNTPs, ddNTPs) Electrophoretic run on sequencer Sequencing lecture Alignment to reference SANGER SEQUENCING: LIMITATIONS Analytical sensitivity*: 99% PCR-Based no detection deletion/duplication rearrangements del/dup BRCA = 4-28% of all BRCA mutations in most population** Level of mosaicism > 20% Low throughput (82496 capillary tubes) Labor intensive Time consuming High cost (large size gene or more genes)
20160219 - S. De Toffol - Dal Sanger al NGS nello studio delle mutazioni BRCA